A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD˗9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure

  • Iansek, Robert (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/54632/MH-2019
NMA SSA Reference Number: SSA/54632/MonH-2020-226380(v1)
Monash Health Reference: RES-20-0000-576X
Effective start/end date8/09/207/09/25


  • clinical trial
  • treatment efficacy
  • phase 3 study
  • Parkinson's disease